Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/beta-catenin pathway activity.
about
Wnt signaling: the good and the badIdentification of a set of KSRP target transcripts upregulated by PI3K-AKT signalingMesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1The position of the amino group on the benzene ring is critical for mesalamine's improvement of replication fidelity.WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer.Quantification of beta-catenin signaling components in colon cancer cell lines, tissue sections, and microdissected tumor cells using reaction monitoring mass spectrometry.Concept of chemoprevention in colorectal cancer.Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}.Five-aminosalicylic Acid: an update for the reappraisal of an old drugOverexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer.5-ASA affects cell cycle progression in colorectal cells by reversibly activating a replication checkpoint.Combination of metformin and 5-aminosalicylic acid cooperates to decrease proliferation and induce apoptosis in colorectal cancer cell linesMesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre miceWnt/β-catenin signaling plays a key role in the development of spondyloarthritis.The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ.Radiographic and endoscopic regression of metastatic gastric cancer to the colon in the setting of 5-aminosalicylic acid use.Colorectal cancer chemoprevention by mesalazine and its derivatives.Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer.PP2A-Mediated Anticancer Therapy.The application of RNAi-based treatments for inflammatory bowel disease.miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cellsChemoprevention of colorectal cancer in inflammatory bowel disease.Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases.p53 Plays an important role in cell fate determination after exposure to microcystin-LR.Favourable effects of grape seed extract on intestinal epithelial differentiation and barrier function in IL10-deficient mice.Wnt/β-catenin Signaling in Osteoarthritis and in Other Forms of Arthritis.Molecular basis of the potential of mesalazine to prevent colorectal cancer.5-aminosalicylic acid interferes in the cell cycle of colorectal cancer cells and induces cell death modes.
P2860
Q24653563-311DC911-71B1-44A3-A4D9-81DD65FADB02Q28222344-F0CD03A8-F15A-4747-87D7-BEEB593EFF0AQ28279134-8E1C65FE-94EE-4D89-9D46-950B808F5676Q33509847-F4FC5ED9-831B-4428-893B-C9D4773D530AQ33572324-7377E552-0952-4596-AF84-BD9F826B5FA5Q33621574-7031F8F0-74BE-424C-BECE-D68D2F100B47Q34390842-8F99A271-4AD6-4CCD-B8CA-45D59383F25CQ34808205-14131180-1732-426A-8C3C-F226258B0E81Q35061210-186C7D18-5BC7-4DF1-953D-CFD884E896F6Q35136001-B8552BF7-34E9-4428-AB4A-5F328BD8BB92Q35728207-CD4628E2-CFC1-464C-8493-57B61CA99B6BQ35928999-4A2F18F7-0D23-46B3-8974-B1C5914182C7Q36374855-3B4F5D65-1D7C-42DE-8636-36D730B7276CQ36717343-BC1656B1-5664-4D30-88A8-9AFC05F05FDBQ37262181-4715F80C-AF69-4C43-87AF-881D8F278A98Q37525344-E95EDA4F-E7F7-4A94-B0B7-65E57D4F0477Q38018938-E6127993-4688-4963-B431-969E25B97282Q38134308-F70973C8-F1EB-47CB-895A-9EF6DB12C224Q38168831-DB844D29-B942-41EF-BD3A-853197070FF4Q38382964-B1006F6D-F689-45B7-8320-697E858E94CAQ38554814-FE297669-DEAD-415D-9044-88350FD9E7BAQ39016806-E73DE60A-94E4-47EA-A880-A7C9B1C7C49AQ39037684-FB4A4CF6-D948-4C65-9322-55E3ED2F14A0Q39710655-44D0D912-42AF-4D21-BCAE-EA87740C3ED8Q40922383-7769D950-A7D3-46F4-ACEE-98D31CB72759Q42965984-19F16DE5-153B-4B19-8CFF-27B4ED0AE296Q43064986-FD2DD59B-0405-431F-AE13-878A7AA72153Q43272637-E9A338EC-0FC8-4B87-9214-A2D1E6989D94
P2860
Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/beta-catenin pathway activity.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Protein phosphatase 2A is requ ...... beta-catenin pathway activity.
@en
type
label
Protein phosphatase 2A is requ ...... beta-catenin pathway activity.
@en
prefLabel
Protein phosphatase 2A is requ ...... beta-catenin pathway activity.
@en
P2093
P356
P1433
P1476
Protein phosphatase 2A is requ ...... beta-catenin pathway activity.
@en
P2093
Carina L Bos
Dick J Richel
James C H Hardwick
Kimberley V Walburg
Sander H Diks
P304
P356
10.1093/CARCIN/BGL071
P407
P577
2006-05-25T00:00:00Z